中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
上海药物研究所 [14]
长春应用化学研究所 [7]
合肥物质科学研究院 [5]
过程工程研究所 [4]
高能物理研究所 [2]
金属研究所 [1]
更多
采集方式
OAI收割 [38]
iSwitch采集 [2]
内容类型
期刊论文 [40]
发表日期
3111 [1]
2024 [2]
2023 [1]
2022 [2]
2021 [4]
2020 [2]
更多
学科主题
Materials ... [1]
筛选
浏览/检索结果:
共40条,第1-10条
帮助
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
题名升序
题名降序
提交时间升序
提交时间降序
作者升序
作者降序
发表日期升序
发表日期降序
ABT-263 enhances sorafenib-induced apoptosis associated with Akt activity and the expression of Bax and p21 (CIP1/WAF1) in human cancer cells1
期刊论文
OAI收割
出版物, 3111, 期号: 0, 页码: 1-35
作者:
Jingru Li
;
Yicheng Chen
;
Jiali Wan
;
Xin Liu
;
Chunrong Yu
  |  
收藏
  |  
浏览/下载:262/0
  |  
提交时间:2017/07/24
Abt-263
Sorafenib
Combination Therapy
Cancer
Resveratrol enhances the antiliver cancer effect of cisplatin by targeting the cell membrane protein PLA2
期刊论文
OAI收割
FRONTIERS IN ONCOLOGY, 2024, 卷号: 14
作者:
Gao, Yu
;
Yang, Zhanyi
;
Bajpai, Akhilesh Kumar
;
Wang, Wenben
;
Zhang, Liyuan
  |  
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2024/11/20
combination therapy
resveratrol
cisplatin
anti-liver cancer mechanism
cell membrane
PLA2
Tumor-targeted PROTAC prodrug nanoplatform enables precise protein degradation and combination cancer therapy
期刊论文
OAI收割
ACTA PHARMACOLOGICA SINICA, 2024, 页码: 12
作者:
Zou, Zhi-feng
;
Yang, Lei
;
Nie, Hui-jun
;
Gao, Jing
;
Lei, Shu-min
  |  
收藏
  |  
浏览/下载:16/0
  |  
提交时间:2024/05/22
proteolysis-targeting chimeras
tumor-targeted delivery
precise protein degradation
combination therapy
triple-negative breast cancer
Hedgehog pathway orchestrates the interplay of histone modifications and tailors combination epigenetic therapies in breast cancer
期刊论文
OAI收割
ACTA PHARMACEUTICA SINICA B, 2023, 卷号: 13, 期号: 6, 页码: 2601-2612
作者:
Wang, Xiaomin
;
Xu, Jun
;
Sun, Yiming
;
Cao, Siyuwei
;
Zeng, Hanlin
  |  
收藏
  |  
浏览/下载:44/0
  |  
提交时间:2023/10/17
HDAC inhibitors
Drug resistance
Histone methylation
Histone acetylation
Epigenetic interplay
Hedgehog pathway
ZIC1
LIFR
Combination therapy
Breast cancer
Lenvatinib- and vadimezan-loaded synthetic high-density lipoprotein for combinational immunochemotherapy of metastatic triple-negative breast cancer
期刊论文
OAI收割
ACTA PHARMACEUTICA SINICA B, 2022, 卷号: 12, 期号: 9, 页码: 3726-3738
作者:
Zheng, Chao
;
Zhang, Wen
;
Wang, Jinming
;
Zhai, Yihui
;
Xiong, Fengqin
  |  
收藏
  |  
浏览/下载:55/0
  |  
提交时间:2022/12/13
KEY WORDS High-density lipoprotein
Immunotherapy
Combination therapy
Metastasis
Triple-negative breast cancer
Lenvatinib
Vadimezan
Immune checkpoint blockade
Self-assembled Pt(II) metallacycles enable precise cancer combination chemotherapy
期刊论文
OAI收割
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2022, 卷号: 119
作者:
Zhang, Pengge
;
Zhou, Zhixuan
;
Long, Wen
;
Yan, Yuping
;
Li, Youshan
  |  
收藏
  |  
浏览/下载:31/0
  |  
提交时间:2022/12/22
self-assembly
supramolecular coordination complex
combination chemotherapy
targeted cancer therapy
drug delivery
If small molecules immunotherapy comes, can the prime be far behind?
期刊论文
OAI收割
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 卷号: 218
作者:
Zhang, Jingyu
;
Zhang, Yu
;
Qu, Bingxue
;
Yang, Haiyan
;
Hu, Shengquan
  |  
收藏
  |  
浏览/下载:63/0
  |  
提交时间:2021/06/15
Cancer immunotherapy
Small molecule inhibitors
Combination therapy
Tumor microenvironment
Discovery of novel ceramide analogs with favorable pharmacokinetic properties and combination with AKT inhibitor against colon cancer
期刊论文
OAI收割
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 卷号: 215, 页码: 13
作者:
Gao, Feng
;
Chen, Xiaoxu
;
Lu, Junyan
;
Hu, Shulei
;
Xu, Hui
  |  
收藏
  |  
浏览/下载:29/0
  |  
提交时间:2021/05/24
Ceramide analogs
AKT inhibitor
MK2206
Colon cancer
Combination therapy
Remarkable Response of Toripalimab Combined with Chemotherapy in Sarcomatoid Carcinoma of Palatine Tonsil: A Case Report
期刊论文
OAI收割
JOURNAL OF MULTIDISCIPLINARY HEALTHCARE, 2021, 卷号: 14
作者:
Huang, Jiahuan
;
Lei, Lei
;
Chen, Bo
;
Pan, Guoqiang
;
Wang, Xiaojiao
  |  
收藏
  |  
浏览/下载:37/0
  |  
提交时间:2021/04/26
chemotherapy
combination therapy
palatine tonsil cancer
PD-1 inhibitor
sarcomatoid carcinoma
Allosteric Inhibitors of SHP2: An Updated Patent Review (2015-2020)
期刊论文
OAI收割
CURRENT MEDICINAL CHEMISTRY, 2021, 卷号: 28, 期号: 19, 页码: 3825-3842
作者:
Wu, Jingwei
;
Zhang, Huan
;
Zhao, Guilong
;
Wang, Runling
  |  
收藏
  |  
浏览/下载:20/0
  |  
提交时间:2021/08/17
SHP2 inhibitor
PTPN11 gene
allosteric
cancer
combination therapy
clinical trial